-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Wins Multiple Prestigious Awards on China’s Most Influential List in the Pharmaceutical Industry
Category:
发布时间：2022-12-10
【概要描述】
Recently, the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce released its 2021 list of the most influential entities in the pharmaceutical industry. In this highly anticipated industry recognition event, Shijiazhuang Sihua Pharmaceutical Co., Ltd. was ranked 36th on the “Top 100 Chinese Pharmaceutical Manufacturers 2021” list and was also honored as a “Law-Abiding and Integrity-Based Enterprise in China’s Pharmaceutical Industry” and a “Pioneer in Independent Innovation in China’s Pharmaceutical Industry.”
Recently, the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce released its 2021 list of the most influential entities in the pharmaceutical industry. In this highly anticipated industry recognition event, Shijiazhuang Sihua Pharmaceutical Co., Ltd. was ranked 36th on the “Top 100 Chinese Pharmaceutical Manufacturers 2021” list and was also honored as a “Law-Abiding and Integrity-Based Enterprise in China’s Pharmaceutical Industry” and a “Pioneer in Independent Innovation in China’s Pharmaceutical Industry.”
Since last year, Shijiazhuang Sihua Pharmaceutical has seized development opportunities, strengthened its sense of responsibility and commitment, and aligned its efforts with the goal of ensuring smooth dual circulation in both domestic and international markets. By leveraging its comparative advantages and building competitive strengths, the company has accelerated its transformation and upgrading, continuously optimized its industrial structure, and shifted its development model from scale-driven growth to innovation-driven growth. As a result, it has demonstrated rapid and steady development, achieved significant economic and social benefits, and consistently delivered impressive performance results. Su Xuejun, Chairman of Shijiazhuang Sihua Pharmaceutical, stated that the company will further extend, supplement, and strengthen its industrial chain; actively integrate its internal resources—including raw materials, talent, technology, and capital—while strategically aligning industrial chains with innovation chains and vice versa. The company is committed to achieving new breakthroughs in overall scale, product mix, and development quality, and to accelerating its move up the value chain toward the mid- to high-end segments.
According to reports, the “Most Influential Rankings in China’s Pharmaceutical Industry” initiative, organized by the Pharmaceutical Industry Chamber of the All-China Federation of Industry and Commerce, has been successfully held for nine consecutive sessions. The event aims to promote industry development and maximize the influence of the winning enterprises and individuals. With its comprehensive coverage of the entire industrial chain, strong representativeness, and high level of participation, the initiative has become a prestigious and authoritative brand event in China’s pharmaceutical sector.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091